If she doesn't have good data then she paid way too much for those shares. The would be hella cheaper next year if the trial is not going to succeed. All longs only chance is this trial succeeding.
Company management is blinded to the trial results. How many times does this need to be reiterated?
LP only knows that she needs money to keep the lights on. Let's go back to what Dr. Liau has always said about this trial..."the longer this trial goes on, the better the results will be."
I'm comfortable with my chips on the table for this one. What is a successful trial worth? 1 billion? 2 billion? If DCVAX L becomes the new standard of care for GBM, I think that might be undervalued. Now imagine if DC Direct has a successful phase 3 trial. Then Opdivo and DCVAX L combined show efficacy in recurrent GBM. Immunotherapy could be the future of cancer care and NWBO could end up being a market leader in 10-15 years. Think 100-200 billion market cap in that scenario.
My personal hope is that people barfing in chemo chairs becomes a relic of medicine just like smallpox and polio are.
News 
Market Data 
Discover 
AI
